Director, Pneumococcal Vaccine RWE
Pfizer Inc.
Disclosure(s): Pfizer Inc.: Employee of Pfizer Inc. and may hold stock or stock options
Kayte Andersen is the Director of Pneumococcal Vaccine Real-World Evidence and Epidemiology as a pharmacoepidemiologist. At Pfizer, she implements causal inference and machine learning techniques to answer population-level questions related to vaccine-preventable disease burden, vaccines, therapeutic products and diagnostic tests. She holds a BSc in Pharmacology & Therapeutics from McGill University, an MSc focused on pharmacoepidemiology from McGill University, and a PhD in Epidemiology with a graduate certificate in pharmacoepidemiology and drug safety from the Johns Hopkins Bloomberg School of Public Health.